GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $6,000 | +20.0% | 160 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | +25.0% | 160 | 0.0% | 0.00% | – |
Q3 2021 | $4,000 | -33.3% | 160 | 0.0% | 0.00% | – |
Q2 2021 | $6,000 | -14.3% | 160 | 0.0% | 0.00% | – |
Q1 2021 | $7,000 | -68.2% | 160 | -68.0% | 0.00% | – |
Q4 2020 | $22,000 | -38.9% | 500 | -23.1% | 0.00% | – |
Q3 2020 | $36,000 | -42.9% | 650 | -35.0% | 0.00% | – |
Q2 2020 | $63,000 | -95.9% | 1,000 | -98.0% | 0.00% | -100.0% |
Q3 2017 | $1,553,000 | +13.5% | 50,009 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $1,368,000 | +308.4% | 50,009 | +115.9% | 0.01% | +200.0% |
Q4 2016 | $335,000 | – | 23,160 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
Grace Capital | 244,914 | $12,882,000 | 6.14% |
Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |